je.st
news
Amgen's bone drug succeeds in late-stage study
2015-09-02 07:45:14| Biotech - Topix.net
Amgen Inc said its experimental bone drug was found to be more effective than an already marketed drug in a late-stage study. Amgen's drug, romosozumab, met the main goal of showing a significant difference over Eli Lilly & Co's teriparatide in improving total hip bone density by the 12th month in postmenopausal women with osteoporosis.
Tags: study
drug
bone
succeeds
Category:Biotechnology and Pharmaceuticals